Drug induced pseudoporphyria in CKD: A case report

Pseudoporphyria (PP) is used to describe a photodistributed bullous disorder with clinical and histologic features of porphyria cutanea tarda (PCT) but without accompanying biochemical porphyrin abnormalities. Medications, excessive sun and ultraviolet radiation exposure, have all been reported to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Quaiser, S., Khan, R., Khan, A. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588329/
https://www.ncbi.nlm.nih.gov/pubmed/26628799
http://dx.doi.org/10.4103/0971-4065.160335
_version_ 1782392602900824064
author Quaiser, S.
Khan, R.
Khan, A. S.
author_facet Quaiser, S.
Khan, R.
Khan, A. S.
author_sort Quaiser, S.
collection PubMed
description Pseudoporphyria (PP) is used to describe a photodistributed bullous disorder with clinical and histologic features of porphyria cutanea tarda (PCT) but without accompanying biochemical porphyrin abnormalities. Medications, excessive sun and ultraviolet radiation exposure, have all been reported to develop PP. We report a case of PP in a 49-year-old man with CKD stage 3a, caused due to torsemide intake. This is probably the first reported case of PP developing in a dialysis naive patient CKD due to torsemide intake from India.
format Online
Article
Text
id pubmed-4588329
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-45883292015-12-01 Drug induced pseudoporphyria in CKD: A case report Quaiser, S. Khan, R. Khan, A. S. Indian J Nephrol Case Report Pseudoporphyria (PP) is used to describe a photodistributed bullous disorder with clinical and histologic features of porphyria cutanea tarda (PCT) but without accompanying biochemical porphyrin abnormalities. Medications, excessive sun and ultraviolet radiation exposure, have all been reported to develop PP. We report a case of PP in a 49-year-old man with CKD stage 3a, caused due to torsemide intake. This is probably the first reported case of PP developing in a dialysis naive patient CKD due to torsemide intake from India. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4588329/ /pubmed/26628799 http://dx.doi.org/10.4103/0971-4065.160335 Text en Copyright: © Indian Journal of Nephrology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Case Report
Quaiser, S.
Khan, R.
Khan, A. S.
Drug induced pseudoporphyria in CKD: A case report
title Drug induced pseudoporphyria in CKD: A case report
title_full Drug induced pseudoporphyria in CKD: A case report
title_fullStr Drug induced pseudoporphyria in CKD: A case report
title_full_unstemmed Drug induced pseudoporphyria in CKD: A case report
title_short Drug induced pseudoporphyria in CKD: A case report
title_sort drug induced pseudoporphyria in ckd: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588329/
https://www.ncbi.nlm.nih.gov/pubmed/26628799
http://dx.doi.org/10.4103/0971-4065.160335
work_keys_str_mv AT quaisers druginducedpseudoporphyriainckdacasereport
AT khanr druginducedpseudoporphyriainckdacasereport
AT khanas druginducedpseudoporphyriainckdacasereport

Ejemplares similares